icon globe EN
Available summer 2026

neffy® is a NEW epinephrine nasal spray for patients weighing 30 kg or more for the emergency treatment of severe allergic reactions including anaphylaxis and is now authorized in Canada.

Hand with neffy device

Device shown is not actual size.

Hand with neffy device
Hand with neffy device

What is neffy®?

neffy® is used in adults and children with a body weight of 30 kg or more for the emergency treatment of allergic reactions, including anaphylaxis (sudden, severe and sometimes life-threatening allergic reactions), to insect stings or bites, foods, medicines and other allergens (substances that cause an allergy) as well as anaphylaxis caused by exercise.

neffy® is intended for immediate self-administration by a person (or given to a person by a caregiver or medical professional) with
a history or recognised risk of a severe allergic reaction that can lead to anaphylactic shock.

Epinephrine nasal spray

neffy® contains epinephrine, the recommended emergency treatment for anaphylaxis, and is a new needle-free device.

Small in size

neffy® is a small-size epinephrine device authorized in Canada*

*neffy® measures 5.7 cm x 4.4 cm x 1.9 cm.

30-month shelf life

neffy® has a shelf life of up to 2.5 years

‡ From date of manufacture.
Storage information

Store at room temperature (15°C to 30°C). If neffy® freezes, thaw for at least one hour before use.†^

†If accidentally frozen, the nasal spray device will not work. Do not use if the contents are still frozen or not completely thawed.
^Clinical significance has not been established

How does neffy® work?

neffy® works directly on the cardiovascular (heart and blood circulation) and respiratory (lung) systems to stop the possible fatal effects of a severe allergic reaction that can lead to anaphylactic shock.

Device shown is not actual size.
Hand holding neffy device

When will neffy® be available in Canada?

Available summer 2026

Join our list to learn more and be notified when neffy® is available

How can I learn more about neffy®?

Patients & Caregivers

Join the neffy® newsletter today to start learning more about neffy® and receive updates on its availability in Canada.

Physicians & Healthcare Providers

Register for the launch webinar and sign up to stay informed about neffy®'s availability in Canada as well as receive helpful resources for your practice.

Reference

neffy® Product Monograph. ALK-Abelló Pharmaceuticals, Inc.